GoodRx Holdings, Inc. operates a digital healthcare platform focused on prescription and medication savings in the United States. Company news commonly covers prescription transaction revenue, retail pharmacy trends, negotiated discount pricing, PBM relationships, and the expansion of Pharma Direct manufacturer programs that connect branded drug discounts to consumers at the pharmacy counter.
GoodRx updates also include self-pay pricing arrangements for GLP-1 and other branded medications, subscription health services such as condition-specific programs, earnings releases, business outlook commentary, and partnerships with pharmaceutical manufacturers, pharmacies, payers, and healthcare professionals.
GoodRx Holdings Inc. (NASDAQ: GDRX) has announced participation in two upcoming investor conferences. The first is the Credit Suisse 25th Annual Technology Conference on December 1, 2021, at 1:20 p.m. PT in Scottsdale, AZ. The second is the Barclays Global Technology, Media and Telecommunications Conference on December 7, 2021, at 11:25 a.m. PT, held virtually. Live webcasts and presentation materials will be accessible on the Company's Investor Relations website, with archived recordings available for 30 days post-conference.
GoodRx has released its State of Telehealth report, highlighting significant changes in telehealth usage due to the COVID-19 pandemic. Over 1,600 providers and patients were surveyed, revealing that 40% of consumers feel they interact more with providers via telehealth. Additionally, 70% of providers noted improved continuity of care. Post-pandemic, 60% of consumers plan to adopt a hybrid model of care. While 45% of providers reported higher no-show rates for telehealth appointments, overall satisfaction remains high, with GoodRx's telehealth service achieving a 92% satisfaction rate and saving consumers an estimated $243 million in medical costs.
GoodRx Holdings, Inc. (GDRX) announced its third quarter 2021 financial results, highlighting its role as a digital healthcare resource that has saved consumers $35 billion since inception in 2011. The company hosted a conference call on November 10, 2021, at 2:00 PM PT to discuss these results and its business outlook. GoodRx is recognized as one of the most downloaded medical apps, emphasizing its significant impact on healthcare affordability and access in the U.S.
GoodRx Holdings Inc. (NASDAQ: GDRX) will release its third quarter 2021 financial results on November 10, 2021, after U.S. market close. A conference call will follow at 2:00 p.m. PT (5:00 p.m. ET), discussing the results and future business outlook. A press release with a link to a shareholder letter will be available on their investor relations website prior to the call. GoodRx, since its inception in 2011, has saved consumers over $30 billion in healthcare costs and remains a leading medical app in the U.S.
GoodRx Holdings, Inc. (Nasdaq: GDRX) will present at the Morgan Stanley Annual Spark Conference on Thursday, October 14, at 1:15 p.m. PT in Beverly Hills, CA. The presentation can be streamed live via the Company's Investor Relations website, with an archived version available for at least 30 days afterward. GoodRx is a digital healthcare resource that has saved consumers over $30 billion since 2011, aiming to make healthcare affordable and accessible for all Americans.
GoodRx has partnered with Fetch Rewards, enabling its 10 million active users to earn rewards points when using GoodRx coupons for medications. This collaboration allows users to access significant medication discounts at over 70,000 pharmacies nationwide, with potential savings of up to 80%. Fetch users can seamlessly integrate these savings and receive rewards that may be redeemed for gift cards or donations. The partnership aims to support millions who struggle with medication affordability and enhance user engagement through Fetch's loyalty program.
GoodRx (GDRX) has launched GoodRx Health, a platform providing research-based answers to health questions. This initiative aims to deliver concise, actionable knowledge through various tools including GoodRx Answers and award-winning videos. The platform is backed by an editorial team of doctors and pharmacists, focusing on areas like health knowledge, financial guidance, and trustworthy research. With nearly 20 million monthly users, GoodRx seeks to enhance consumer advocacy in healthcare decisions and capture a larger share of the $30 billion addressable market.
GoodRx Holdings (GDRX) will host a virtual educational webinar, GoodRx 101, for analysts and investors on September 30, 2021, at 11:30 a.m. PT (2:30 p.m. ET). The session will provide an overview of the company's business, though no new financial information will be disclosed. Participants can join via the webcast at investors.goodrx.com or use the dial-in number (833) 614-1447. An archived version of the presentation will be accessible for 30 days post-event.
GoodRx is a leading digital healthcare resource, having helped consumers save over $30 billion since its inception in 2011.
Summary not available.
Summary not available.